{
    "pmcid": "8606259",
    "qa_pairs": {
        "How do nanobodies neutralize SARS-CoV-2 according to the paper?": [
            "By blocking the virus's entry into host cells through targeting the spike glycoprotein",
            "By enhancing the immune system's response to infected cells",
            "By directly lysing the viral particles in the bloodstream",
            "By preventing the replication of viral RNA within host cells"
        ],
        "What are the primary advantages of nanobodies in therapeutic applications against SARS-CoV-2?": [
            "Low toxicity, high affinity, and specificity to target proteins",
            "Large size and ability to bind multiple epitopes simultaneously",
            "High immunogenicity and rapid clearance from the body",
            "Ability to induce a strong inflammatory response"
        ],
        "What future research direction is suggested for improving nanobody design against SARS-CoV-2?": [
            "Creating comprehensive mutation maps and employing deep mutational scanning",
            "Developing larger nanobodies with increased binding sites",
            "Focusing on the development of bispecific antibodies",
            "Increasing the immunogenicity of nanobodies to enhance immune response"
        ],
        "What is a significant challenge in the efficacy of nanobodies against SARS-CoV-2 as mentioned in the paper?": [
            "Emergence of mutations in the S-glycoprotein that facilitate antibody escape",
            "High production costs and complex manufacturing processes",
            "Limited availability of camelid-derived antibodies",
            "Inability to penetrate the blood-brain barrier"
        ],
        "What is the role of tetravalent nanobodies in combating antibody escape?": [
            "They improve resistance by potentially binding multiple epitopes, reducing escape likelihood",
            "They increase the size of the nanobody, making it more effective",
            "They enhance the immune response by recruiting additional immune cells",
            "They decrease the affinity for the spike protein, allowing for broader application"
        ]
    }
}